Patent cliffs & loss of exclusivity
Neurocrine Biosciences is a neuroscience-focused biopharmaceutical company based in San Diego, dedicated to discovering and developing treatments for patients with neurological, psychiatric and endocrine disorders. Founded in 1992, its marketed medicines include INGREZZA and CRENESSITY.
| AngelList URL | https://angel.co/neurocrine-biosciences |
|---|---|
| CAGE Code | 5H9C3 |
| Legal Name | Neurocrine Biosciences, Inc. |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/neurocrine-biosciences |
| Email format | {f}{last} |
| Facebook URL | https://www.facebook.com/neurocrine/ |
| Fax Number | (858) 617-7602 |
Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.